Product image of Naropin Bag 100 Ml (Ropivacaine Hydrochloride) supplied by GNH India

Naropin Bag 100 Ml

Active Ingredient:
Ropivacaine Hydrochloride
Origin:
EU

Naropin Bag 100 Ml (Ropivacaine Hydrochloride)

Ropivacaine Hydrochloride, the active ingredient in Naropin Bag 100 Ml, is a local anesthetic (amide type) presented as a solution for injection (bag) for epidural and infiltration use. It provides regional anesthesia for surgical procedures and pain management in adult patients.

GNH India supplies Naropin Bag 100 Ml as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Aspen Pharma Trading Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ropivacaine Hydrochloride is a long‑acting amide local anesthetic used to achieve regional nerve block in various clinical settings.

  • Epidural anesthesia: provides surgical anesthesia and postoperative analgesia during obstetric, abdominal or orthopedic procedures.
  • Infiltration anesthesia: delivers local numbness for minor surgical or diagnostic procedures.
  • Peripheral nerve block: produces targeted anesthesia for limb surgeries.

How It Works

  • Ropivacaine Hydrochloride reversibly blocks voltage‑gated sodium channels on neuronal membranes, inhibiting the initiation and propagation of action potentials. This selective inhibition of nerve impulse transmission preferentially affects sensory fibers, producing profound regional anesthesia while sparing motor function at lower concentrations.

Side Effects

Ropivacaine may cause a range of adverse reactions, from mild to severe, depending on dose and patient factors.

Common Side Effects

  • Hypotension: transient drop in blood pressure.
  • Bradycardia: slowed heart rate.
  • Nausea: mild gastrointestinal upset.
  • Vasodilation: flushing or warmth at the injection site.
  • Transient motor weakness: temporary reduction in muscle strength.
  • Injection site pain: discomfort at the site of administration.

Serious or Rare Side Effects

  • Cardiac arrhythmias: irregular heart rhythms that may be life‑threatening.
  • Seizures: central nervous system excitation.
  • Systemic toxicity: CNS symptoms such as tinnitus, metallic taste, or confusion.
  • Allergic reactions: including anaphylaxis.
  • Methemoglobinemia: reduced oxygen‑carrying capacity of blood.

Precautions & Warnings

When using Naropin Bag 100 mL, clinicians should observe specific safety measures.

  • Dose adjustment: consider reduced dose in elderly or patients with hepatic impairment.
  • Monitoring: observe cardiovascular and CNS status during and after administration.
  • Contraindications: avoid in patients with known hypersensitivity to amide‑type local anesthetics.
  • Pregnancy: use only if the potential benefit justifies the potential risk; data are limited.
  • Drug interactions: avoid concurrent use with other potent local anesthetics.
  • Store at ambient temperature: keep in the original packaging, protect from light and moisture.

Avoid Interactions

Ropivacaine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Class I antiarrhythmics (e.g., quinidine, procainamide): may increase cardiotoxicity.
  • Beta‑blockers: can potentiate bradycardia and hypotension.
  • High‑dose general anesthetics (e.g., propofol): may enhance central nervous system depression.

Moderate Interactions (Monitor Closely)

  • Opioids: additive sedation and respiratory depression.
  • Non‑steroidal anti‑inflammatory drugs: may increase bleeding risk.

Frequently Asked Questions

Naropin Bag 100 mL contains ropivacaine hydrochloride and is used to provide regional anesthesia for epidural, infiltration and peripheral nerve block techniques. It is employed in surgical procedures and postoperative pain management to achieve targeted numbness while preserving motor function when appropriate.

Ropivacaine blocks voltage‑gated sodium channels on neuronal membranes, preventing the initiation and propagation of nerve impulses. By inhibiting these channels, it stops the transmission of pain signals from the site of injection to the central nervous system, resulting in localized loss of sensation.

The specific dose of Naropin Bag 100 mL is determined by the prescribing clinician based on the type of procedure, patient characteristics, and desired depth of anesthesia. Dosing guidelines are provided in the product’s prescribing information and must be individualized for each patient.

Safety data for ropivacaine during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Both ropivacaine and bupivacaine are amide‑type long‑acting local anesthetics. Ropivacaine tends to have a slightly lower propensity for cardiotoxicity and provides a better sensory‑motor block separation, making it a preferred choice for procedures where rapid motor recovery is desirable.

Store the bag at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from direct light, moisture and extreme temperatures. Do not freeze or shake the solution before use, and inspect the container for any leaks or discoloration prior to administration.

Naropin is administered by a qualified healthcare professional via epidural, infiltration or peripheral nerve block techniques. The solution is injected using sterile equipment, and the volume and concentration are adjusted according to the specific clinical indication and patient response.

Serious risks include cardiovascular toxicity such as arrhythmias, severe hypotension, central nervous system toxicity leading to seizures, and rare allergic reactions including anaphylaxis. Prompt recognition and supportive management are essential if any of these events occur.

Patients with a known hypersensitivity to ropivacaine, other amide‑type local anesthetics, or any component of the formulation should not receive Naropin. It is also contraindicated in individuals with certain severe cardiac conduction disorders unless the benefits clearly outweigh the risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ropivacaine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT